37.09 +0.31 (0.84%)
After hours: 4:51PM EDT
|Bid||37.00 x 800|
|Ask||36.73 x 900|
|Day's range||36.28 - 37.74|
|52-week range||24.01 - 56.92|
|Beta (5Y monthly)||1.47|
|PE ratio (TTM)||N/A|
|Earnings date||16 Jul 2020|
|Forward dividend & yield||1.80 (4.72%)|
|Ex-dividend date||14 May 2020|
|1y target est||41.11|
Excluding these costs and fee rebates, Truist earned $1.2 billion , or $0.87 per share for the quarter. In this challenging time, we are fortunate to have the ability to fulfill that purpose and support our Truist family and stakeholders, help stabilize the economy and look forward to a recovery in the future.
Reported results for Truist reflect heritage BB&T prior to the completion of the merger and results from both BB&T and SunTrust from the merger closing date forward. The merger of equals resulting in the formation of Truist was completed on December 6, 2019 . Net income available to common shareholders was $702 million , down 6.9 percent, compared with the fourth quarter last year due to costs associated with the merger.
TORONTO , Dec. 16, 2019 /CNW/ - Trichome Financial Corp. ("Trichome Financial" or the "Company") (CSE: TFC) today announced that the Company has signed a non-binding term sheet to provide up to $11.5 million in senior secured debt financing to Ontario Cannabis Holdings Corp. ("OCH") or affiliates thereof. Trichome Financial has built considerable expertise in the retail sector, with successful loans made to both C.G.S Foods Inc. (d/b/a Ganjika House), a lottery winner from the first round of the Alcohol and Gaming Commission of Ontario ("AGCO") licensing process in March 2019 , and 180 Smoke prior to its sale to Origin House (CSE: OH), as well as reviewing numerous retail opportunities across Canada.
TORONTO , Nov. 26, 2019 /CNW/ - Trichome Financial Corp. (formerly 22 Capital Corp.) (the "Company" or "Trichome Financial") (TSXV: TFC) is pleased to announce it has received conditional approval to list its common shares on the Canadian Securities Exchange (the "CSE"). Successful listing on the CSE will allow the Company to expand its addressable market for credit solutions to include the cannabis sector in the United States .
TORONTO , Oct. 10, 2019 /CNW/ - Trichome Financial Corp. (formerly 22 Capital Corp.) (the "Company" or "Trichome Financial") (TSXV: TFC) is pleased to announce that its common shares will begin trading on the TSX Venture Exchange ("TSXV") today under the trading symbol "TFC".
TORONTO , Oct. 9, 2019 /CNW/ - Trichome Financial Corp. (formerly 22 Capital Corp.) (the "Company" or "Trichome Financial") (TSXV: TFC) is pleased to announce that its common shares will begin trading on the TSX Venture Exchange ("TSXV") tomorrow under the trading symbol "TFC".
TORONTO , Oct. 7, 2019 /CNW/ - On October 4, 2019 , Trichome Financial Corp. (the "Corporation" or "Trichome Financial") and 22 Capital Corp. ("22 Capital") completed a business combination transaction by way of an amalgamation (the "Amalgamation") of Trichome Financial with 22 Capital to form the Corporation. At a shareholder meeting for 22 Capital on July 4, 2019 and a shareholder meeting for Trichome Financial held on July 8, 2019 , the Amalgamation and related matters were approved by the shareholders of each of 22 Capital and Trichome Financial.
TORONTO , Aug. 12, 2019 /CNW/ - 22 Capital Corp. ("22 Capital") and Trichome Financial Corp. (the "Corporation" or "Trichome Financial") announce that, further to their press releases of April 24, 2019 and May 28, 2019 , they have received an extension from the TSX Venture Exchange ("TSXV") with respect to the completion of their announced amalgamation under the provisions of the Business Corporations Act ( Ontario ) that will result in a reverse take-over of 22 Capital by the shareholders of Trichome Financial (the "Transaction"). The outside date upon which final acceptance of the Transaction will be granted by the TSXV has been extended until August 30, 2019 . It is expected that trading of Trichome Financial's common shares will commence two business days after the closing of the Transaction and the receipt of the TSXV's final acceptance.